Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol

NCT02227498 is registered in ClinicalTrials.gov with Second Sight Medical Products as lead sponsor.

NCT NCT02227498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol
Lead sponsor
Second Sight Medical Products
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
March 31, 2020
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration